Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway-Reference-Cited by-同舟云学术

Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway

Published:2011-06 Issue:3 Volume:135 Page:678-684
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Lee Ko-Chen,Chang Hen-Hong,Chung Ying-Hui,Lee Tzung-Yan

Funder

Chang Gung Memorial Hospital

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference37 articles.

1. In vitro and in vivo anti-inflammatory effects of andrographolide;Abu-Ghefreh;International Immunopharmacology,2009

2. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa;Asehnoune;The Journal of Immunology,2004

3. Glutathione levels determine apoptosis in macrophages;Boggs;Biochemistry Biophysics Research Communication,1998

4. A phase I trial of andrographolide in HIV positive patients and normal volunteers;Calabrese;Phytotherapy Research,2000

5. Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis;Callsen;Biochemistry,1999

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide;Gut Microbes;2024-09-12

2. Biomacromolecules as Immunomodulators: Utilizing Nature’s Tools for Immune Regulation;Macromol;2024-09-05

3. Exploring the potential of andrographis paniculata and its bioactive compounds in the management of liver diseases: A comprehensive food chemistry perspective;Food Chemistry Advances;2024-06

4. Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway;Scientific Reports;2024-05-26

5. EP300 improves endothelial injury and mitochondrial dysfunction in coronary artery disease by regulating histone acetylation of SOCS1 promoter via inhibiting JAK/STAT pathway;Cytokine;2024-04